Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro AnalysesYasuhiro Fudaba, Megan Sykes, Thomas R. Spitzer et al.|American Journal of Transplantation|2006Cited by 260
Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burdenRahel Schwotzer, B. Gerber, Thomas Fehr et al.|Hematological Oncology|2019Cited by 34
Targeting apoptosis to induce stable mixed hematopoietic chimerism and long-term allograft survival without myelosuppressive conditioning in micePietro E. Cippà, Thomas Fehr|Blood|2013Cited by 25
Resistance to ABT-737 in activated T lymphocytes: molecular mechanisms and reversibility by inhibition of the calcineurin–NFAT pathwayPietro E. Cippà, Thomas Fehr|Cell Death and Disease|2012Cited by 23
Tubular and endothelial chimerism in renal allografts using fluorescence and chromogenic in situ hybridization (FISH, CISH) technologyZsuzsanna Varga, Thomas Fehr|Pathology International|2012Cited by 14